GEN Exclusives

More »
Regional Development - Related Content
  • Insight & Intelligence™
  • More »
  • BIOTECHNOLOGY IN SPAIN
    - Interview with José María Fernández Sousa-Faro, Ph.D., President of the Spanish Association of Bioenterprises (ASEBIO), and Chairman of the Zeltia Group
  • (BIO) BANKING IN LUXEMBOURG
    - Interview with Robert Hewitt, Ph.D., CEO, Integrated Biobank of Luxembourg, and European Editor, Biopreservation and Biobanking (published by Mary Ann Liebert, Inc.)
  • CHINA'S CHANGING PHARMACEUTICAL LANDSCAPE
    - Interview with Michael Keech, Director, Pharmaceutical and Life Sciences Advisory Services Group, PricewaterhouseCoopers
  • BIOTECHNOLOGY IN GEORGIA
    - Interview with Charles Craig, President of Georgia Bio; Stephen Hill, President, Solvay Pharmaceuticals, Inc.; and Russell Medford, M.D., Ph.D., President and CEO, Atherogenics, Inc.
  • MAKING NEW YORK CITY A BIO-MECCA
    - Lenzie Harcum, Vice President of Business Development in Biosciences at the New York City Economic Development Corporation, and Bill Fair, Managing Director at Alexandria Real Estate Equities

Jobs

GEN Jobs powered by HireLifeScience.com connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
 Searching...

Unable to get Jobs Listings.

More »

GEN Poll

More » Poll Results »

Biosimilars

Compared to the original biologics, do you think biosimilars run the risks of being less effective and causing more side effects?